Obviously you dont have much knowledge about the market of LVAD's. Upwards of 50,000 patients per year growing at a rate of 10% per year.....times that by $100,000 per device and there's your market.
Sure there are a few companies in this field but they cant sustain the demand now. Only 2,000 heart transplants per year in the US alone shows that the demand for another alternative is needed.
Step in the Ventrassist and if they can manage to add the TETS then it will become the number 1 company for LVAD's.
Please do more research before you post such nonsense.
- Forums
- ASX - By Stock
- VCR
- fair value 70 cents
VCR
ventracor limited
fair value 70 cents, page-2
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online